Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

References for PMC Articles for PubMed (Select 20379742)

1.

Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.

Overbeek LI, Hoogerbrugge N, van Krieken JH, Nagengast FM, Ruers TJ, Ligtenberg MJ, Hermens RP; MIPA Study Group.

Dis Colon Rectum. 2008 Aug;51(8):1249-54. doi: 10.1007/s10350-008-9345-x.

2.

Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.

Overbeek LI, Kets CM, Hebeda KM, Bodmer D, van der Looij E, Willems R, Goossens M, Arts N, Brunner HG, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ.

Br J Cancer. 2007 May 21;96(10):1605-12. Epub 2007 Apr 24.

3.

Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.

Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA.

Cell Oncol. 2007;29(1):19-24.

PMID:
17429138
4.

Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Jass JR.

World J Gastroenterol. 2006 Aug 21;12(31):4943-50. Review.

5.

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.

Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG.

N Engl J Med. 2006 Jun 29;354(26):2751-63.

6.

Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ, de Walle HE, de Vries EG, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH.

Gut. 2006 Dec;55(12):1781-8. Epub 2006 Apr 24.

7.

[More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].

de Bruin JH, Kievit W, Ligtenberg MJ, Nagengast FM, Adang EM, Ruers TJ, Kleibeuker JH, Sijmons RH, van Krieken JH, Hoogerbrugge N.

Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1792-8. Dutch.

PMID:
16121665
8.

Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes.

Shaw B, Cheater F, Baker R, Gillies C, Hearnshaw H, Flottorp S, Robertson N.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005470. Review. Update in: Cochrane Database Syst Rev. 2010;(3):CD005470.

PMID:
16034980
9.

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A.

N Engl J Med. 2005 May 5;352(18):1851-60.

10.

Cost effectiveness of a new strategy to identify HNPCC patients.

Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N.

Gut. 2005 Jan;54(1):97-102.

11.

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S.

Clin Gastroenterol Hepatol. 2004 Sep;2(9):813-9.

PMID:
15354282
12.

CONSORT statement: extension to cluster randomised trials.

Campbell MK, Elbourne DR, Altman DG; CONSORT group.

BMJ. 2004 Mar 20;328(7441):702-8. No abstract available.

13.

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S.

J Natl Cancer Inst. 2004 Feb 18;96(4):261-8.

14.

Effectiveness and efficiency of guideline dissemination and implementation strategies.

Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C.

Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72. Review.

15.

From best evidence to best practice: effective implementation of change in patients' care.

Grol R, Grimshaw J.

Lancet. 2003 Oct 11;362(9391):1225-30. Review.

PMID:
14568747
16.

Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.

Porteous M, Dunckley M, Appleton S, Catt S, Dunlop M, Campbell H, Cull A.

Br J Cancer. 2003 Oct 20;89(8):1400-2.

17.

Hereditary colorectal cancer.

Lynch HT, de la Chapelle A.

N Engl J Med. 2003 Mar 6;348(10):919-32. Review. No abstract available.

18.

Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members.

Katballe N, Juul S, Christensen M, Ørntoft TF, Wikman FP, Laurberg S.

Br J Surg. 2001 Sep;88(9):1228-33.

PMID:
11531872
19.

The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V, Nelson H, Michels VV, Thibodeau SN.

Am J Hum Genet. 2001 Oct;69(4):780-90. Epub 2001 Aug 24. Erratum in: Am J Hum Genet 2001 Nov;69(5):1160.

20.

Family history of colorectal cancer: how often and how accurately is it recorded?

Church J, McGannon E.

Dis Colon Rectum. 2000 Nov;43(11):1540-4.

PMID:
11089589
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk